Verona Pharma Plc (VRNA)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 458k | 0 | 0 | 0 | 0 | 0 | 0 | 5.62M |
営業利益 | -41.66M | -19.89M | -11.9M | -38.33M | -54.08M | -26.61M | -71.23M | -107.99M |
税引前収入 | -10.42M | -16.57M | -8.5M | -14.64M | -14.19M | -25.04M | -69.82M | -42.71M |
純利益 | -10.45M | -16.74M | -8.81M | -14.69M | -14.13M | -25.79M | -70.84M | -42.96M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -32.84M | -19.89M | -11.9M | -38.33M | -52.97M | -26.61M | -71.23M | -107.99M |
EBITDA | -41.51M | -19.73M | -11.74M | -38.18M | -53.87M | -26.35M | -70.96M | -107.73M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 40M | 458k | 0 |
営業利益 | -6.88M | -29.72M | -25.6M | -40.74M | -74.28M | -73.31M | -75.75M | -67.57M |
税引前収入 | -5.97M | -25.2M | -24.13M | -39.21M | -64.97M | -55.59M | -68.45M | -53.9M |
純利益 | -5.02M | -20.5M | -19.9M | -31.94M | -65.11M | -55.57M | -68.7M | -54.37M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.002 | -0.195 | -0.189 | -0.303 | -0.133 | -0.114 | -0.14 | -0.081 |
EBIT | -6.88M | -29.72M | -25.6M | -40.74M | -66.01M | -57.68M | -66.93M | -66.47M |
EBITDA | -6.82M | -29.66M | -25.5M | -40.23M | -73.37M | -72.68M | -75.11M | -66.89M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約